| Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose SJ Hadziyannis, H Sette Jr, TR Morgan, V Balan, M Diago, P Marcellin, ... Annals of internal medicine 140 (5), 346-355, 2004 | 3984 | 2004 |
| Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent J Linnen, J Wages Jr, ZY Zhang-Keck, KE Fry, KZ Krawczynski, H Alter, ... Science 271 (5248), 505-508, 1996 | 2029 | 1996 |
| Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years SJ Hadziyannis, NC Tassopoulos, EJ Heathcote, TT Chang, G Kitis, ... Gastroenterology 131 (6), 1743-1751, 2006 | 1837* | 2006 |
| Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection WF Carman, S Hadziyannis, MJ McGarvey, MR Jacyna, P Karayiannis, ... The Lancet 334 (8663), 588-591, 1989 | 1610 | 1989 |
| Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B P Marcellin, GKK Lau, F Bonino, P Farci, S Hadziyannis, R Jin, ZM Lu, ... New England Journal of Medicine 351 (12), 1206-1217, 2004 | 1522 | 2004 |
| Adefovir dipivoxil for the treatment of hepatitis B e antigen–negative chronic hepatitis B SJ Hadziyannis, NC Tassopoulos, EJ Heathcote, TT Chang, G Kitis, ... New England Journal of Medicine 348 (9), 800-807, 2003 | 1434 | 2003 |
| A proposed system for the nomenclature of hepatitis C viral genotypes P Simmonds, A Alberti, HJ Alter, F Bonino, DW Bradley, C Brechot, ... Hepatology 19 (5), 1321-1324, 1994 | 1348 | 1994 |
| Hepatitis B e antigen–negative chronic hepatitis B SJ Hadziyannis, D Vassilopoulos Hepatology 34 (4), 617-624, 2001 | 1134* | 2001 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 698 | 2003 |
| Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B MR Brunetto, F Moriconi, F Bonino, GKK Lau, P Farci, C Yurdaydin, ... Hepatology 49 (4), 1141-1150, 2009 | 667 | 2009 |
| Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α‐2a (40 kd)/ribavirin therapy DM Jensen, TR Morgan, P Marcellin, PJ Pockros, KR Reddy, ... Hepatology 43 (5), 954-960, 2006 | 664 | 2006 |
| Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B G Fattovich, G Giustina, SW Schalm, S Hadziyannis, J Sanchez-Tapias, ... Hepatology 21 (1), 77-82, 1995 | 582 | 1995 |
| Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen–negative chronic hepatitis B SJ Hadziyannis, GV Papatheodoridis, E Dimou, A Laras, C Papaioannou Hepatology 32 (4), 847-851, 2000 | 545 | 2000 |
| Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBcAg Vs. Anti-HBe positive carriers of hepatitis B virus SJ Hadziyannis, HM Lieberman, GG Karvountzis, DA Shafritz Hepatology 3 (5), 656-662, 1983 | 480 | 1983 |
| Adding‐on versus switching‐to adefovir therapy in lamivudine‐resistant HBeAg‐negative chronic hepatitis B I Rapti, E Dimou, P Mitsoula, SJ Hadziyannis Hepatology 45 (2), 307-313, 2007 | 479 | 2007 |
| Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alfa-2a P Marcellin, F Bonino, GKK Lau, P Farci, C Yurdaydin, T Piratvisuth, R Jin, ... Gastroenterology 136 (7), 2169-2179. e4, 2009 | 410 | 2009 |
| The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B GV Papatheodoridis, E Manesis, SJ Hadziyannis Journal of hepatology 34 (2), 306-313, 2001 | 409 | 2001 |
| Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study G Realdi, G Fattovich, S Hadziyannis, SW Schalm, P Almasio, ... Journal of hepatology 21 (4), 656-666, 1994 | 377 | 1994 |
| Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil C Westland, W Delaney IV, H Yang, S Chen, P Marcellin, S Hadziyannis, ... Gastroenterology 125 (1), 107-116, 2003 | 375 | 2003 |
| Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir SJ Hadziyannis, V Sevastianos, I Rapti, D Vassilopoulos, E Hadziyannis Gastroenterology 143 (3), 629-636. e1, 2012 | 374 | 2012 |
